Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of single-dose losartan combined with CBT on threat bias in panic disorder
2015-003542-68Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in panic disorder comparing CBT + losartan with CBT + placebo (2 arms). Primary endpoint: Threat bias reduction. Status: unknown.
02
Drugs
losartan
03
Conditions
panic disorder
Beyond the preview
Go deeper on 2015-003542-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003542-68.